ChIP-seq analysis in anaplastic thyroid carcinoma cells overexpressing SMARCA2
To assess the function of SMARCA2 in thyroid cancer, we performed ChIP-seq assay in control and SMARCA2 overexpressing CAL-62 cells. Both control cells and SMARCA2 overexpressing cells were reacted with H3K27ac and SMARCA2 antibodies respectively.